Latest Intellectual Property News

Cyclopharm Limited has secured the maximum five-year U.S. patent extension for its flagship Technegas® Kit, extending market exclusivity to 2031 and reinforcing its strategic foothold in pulmonary imaging.

COSOL Limited anticipates solid revenue and earnings growth for FY25 despite some contract timing setbacks, with a promising outlook for FY26 driven by data analytics and managed services expansion.

Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.

ClearVue Technologies’ subsidiary OptiCrop has secured its inaugural commercial project, an $80,000 greenhouse installation leveraging proprietary ground-source heat exchange technology. This milestone underscores ClearVue’s strategic expansion into sustainable protected cropping and greenhouse agriculture.

Everest Metals Corporation has completed a breakthrough engineering study demonstrating 97% rubidium recovery at its Mt Edon project, advancing Australia’s entry into the global rubidium market with a patented extraction process.

INOVIQ Limited has revealed promising data for its EXO-OC™ ovarian cancer screening test, demonstrating exceptional accuracy and flawless detection of early-stage cancers. This innovation could transform early diagnosis and treatment outcomes for women worldwide.

Clean TeQ Water reports a successful lithium extraction pilot and the amicable termination of its LithiumBank agreements, setting the stage for new global deployments of its cDLE® technology.

Iondrive Limited is expanding its proprietary Deep Eutectic Solvent technology into the burgeoning e-waste urban mining sector, backed by a South Australian government grant. The company aims to recover valuable metals from printed circuit boards, tapping into a global market worth billions yet largely unrecycled.

Papyrus Australia has secured a pivotal contract with UniSA to establish a Rapid Prototyping and R&D facility, advancing its sustainable packaging technology and commercial production plans.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

RareX Limited has partnered with Gega Elements to develop Australia’s inaugural integrated gallium supply chain, aiming to reduce reliance on Chinese supply and boost national critical mineral resilience.